Advertisement

Topics

Ligand To Receive $2 Million From Wuxi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody Discovered Using The Omniab Technology

20:00 EDT 17 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Ligand To Receive $2 Million From Wuxi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody Discovered Using The Omniab Technology

NEXT ARTICLE

More From BioPortfolio on "Ligand To Receive $2 Million From Wuxi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody Discovered Using The Omniab Technology"

Advertisement
Quick Search
Advertisement
Advertisement